Opioid Adherence and Support Through Innovative Texting Strategies (NCT07350148)
Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages
Who can join: Review the eligibility criteria below.
Location: University of New Mexico — Albuquerque, New Mexico
Age range: 18 Years
🧪 Interventions in This Study
- Mindfulness text messages (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of New Mexico — Albuquerque, New Mexico
📞 Contact the Study Coordinator
Phone: (505) 456-3014
Email: fschwebel@unm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use Disorder (OUD)
- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) — Little Rock, Arkansas
- Mindfulness Texting for Medication Adherence and Chronic Pain Management — Albuquerque, New Mexico
- Mapping Ibogaine Neural Dynamics in Opioid Use Disorder — Irvine, California
- MethaLoad Dose-Finding Study — Philadelphia, Pennsylvania
- Adjunctive Cannabidiol for Recovery From Opioid Study — New York, New York
Explore by condition: All Opioid Use Disorder (OUD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.